Hilliard Lyons Downgrades Meridian Biosciences (VIVO) to Neutral
Tweet
Share
E-mailGet Alerts VIVO Hot Sheet
Price: $4.36 +3.56%
Rating Summary:
3 Buy, 4 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
3 Buy, 4 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
Hilliard Lyons downgraded Meridian Biosciences (NASDAQ: VIVO) from Long-Term Buy to Neutral.
For an analyst ratings summary and ratings history on Meridian Biosciences click here. For more ratings news on Meridian Biosciences click here.
Shares of Meridian Biosciences closed at $21.36 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- VivoPower plans separate listing for 2.2GW non-Nordic AI platform
- DZ Bank Downgrades Frontline Ltd. (FRO) to Sell
- Goldman Sachs Downgrades Hysan Development Company Limited (14:HK) (HYSNY) to Sell
Create E-mail Alert Related Categories
DowngradesRelated Entities
Hilliard LyonsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
